持股变动声明
$SPK Acquisition(SPK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000902664-23-000043 Size: 7 KB 网页链接
SPK在一份文件中表示,终止交易的原因是Varian Biopharmaceuticals违反了合并协议中包含的一项或多项条款。
今年2月,瓦里安和SPK宣布了合并计划,合并后公司的股权价...查看全文
$SPK Acquisition(SPK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000902664-23-000043 Size: 7 KB 网页链接
$SPK Acquisition(SPK)$ RW Registration Withdrawal Request Accession Number: 0001903596-22-000986 Act: NE Size: 7 KB 网页链接
$SPK Acquisition(SPK)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-22-000803 Act: 34 Size: 3 KB 网页链接
$SPK Acquisition(SPK)$ 8-K/A [Amend] Current report, items 1.02 and 8.01 Accession Number: 0001903596-22-000983 Act: 34 Size: 259 KB 网页链接
$SPK Acquisition(SPK)$ 8-K Current report, items 1.02 and 8.01 Accession Number: 0001903596-22-000949 Act: 34 Size: 255 KB 网页链接
$SPK Acquisition(SPK)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000902664-22-005181 Size: 4 KB 网页链接
$SPK Acquisition(SPK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001903596-22-000808 Act: 34 Size: 2 MB 网页链接
$SPK Acquisition(SPK)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001903596-22-000674 Act: 33 Size: 12 MB 网页链接
$SPK Acquisition(SPK)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001376474-22-000396 Act: 34 Size: 43 KB 网页链接
$SPK Acquisition(SPK)$ 8-K Current report, items 1.01, 2.03, 5.03, 5.07, 8.01, and 9.01 Accession Number: 0001575705-22-000657 Act: 34 Size: 371 KB 网页链接